Friday, May 25, 2018
 
 
Company News: Page (1) of 1 - 05/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Global DNA Sequencing Technologies, Markets and Companies to 2027
 
(May 16, 2018)

DUBLIN, May 16, 2018 /PRNewswire/ --

The "DNA Sequencing - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing them.



Various applications of sequencing are described including those for genetics, medical diagnostics, drug discovery and cancer. Next generation sequencing technologies, both second and third generations, are reviewed. Companies developing software for analysis of sequencing data are also included. Selected academic institutes conducting research in sequencing are also listed.

Current market is mostly for research applications and future markets will be other applications related to healthcare. The value of DNA sequencer market in 2017 is described with estimates for 2022 and 2027. Various methods and factors on which market estimates depend are described briefly. Markets are tabulated according to geographical areas as well as applications. Small sequencers form the basis of SWOT (strengths, weaknesses, opportunities, threats) analysis. Several marketing strategies have been outlined.

The report includes profiles of 142 companies involved in sequencing and their 154 collaborations. The report text is supplemented by 42 tables, 23 figures and 500 selected references to the literature.

Key Topics Covered:

Executive Summary

1. Introduction

2. DNA Sequencing Technologies

3. Role of Bioinformatics in Sequencing

4. Comparative Analysis of Sequencing Technologies

5. Sequencing for Research

6. Applications of Sequencing in Healthcare

7. Applications of Sequencing in Oncology

8. Sequencing in Genetic Disorders

9. Sequencing in Neurological and Psychiatric Disorders

10. Applications of sequencings in infections

11. Role of Sequencing in Personalized Medicine

12. Current Status and Future Prospects

13. Markets for Sequencers

14. Companies Involved in Sequencing

15. References

For more information about this report visit https://www.researchandmarkets.com/research/t9rnbk/global_dna?w=5

Media Contact:


Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-dna-sequencing-technologies-markets-and-companies-to-2027-300649511.html

SOURCE Research and Markets

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Science,Literature,Lifestyle,Medical,Biology,Genetics,Cancer,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Bellevue Asset Management AG: Bellevue launches dedicated digital health fund
  • Study on Poor Oral Hygiene Habits of Aging Population Underlines the Importance of Outstanding Dental Care, says Premier Care Dental Group
  • Blood Gas and Electrolyte Analyzer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2023
  • Interventional Cardiology Devices Market to be worth US$11.16 bn by 2022, Says TMR
  • Medical Fluid Bags Market will register 6.5% CAGR to cross USD 4.4 billion by 2024: Global Market Insights, Inc.

    Cancer
  • Bavarian Nordic Announces Interim Results for the First Three Months of 2018
  • NASP Applauds Bipartisan Legislation Introduced to Reduce Drug Costs and Support Access for Seniors with Life-Threatening Specialized Conditions
  • Celgene Corporation Announces Additional $3 Billion Share Repurchase Authorization and Plans to Execute a $2 Billion Accelerated Share Repurchase Program
  • Moorestown Visiting Nurse Association joins the growing enTouch network in New Jersey
  • Achieve Life Sciences, Inc. Announces Reverse Stock Split
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines